Results of salvage therapy with mini-hyper-CVD and inotuzumab ozogamicin with or without blinatumomab in pre-B acute lymphoblastic leukemia

BACKGROUND: Historically, adults with relapsed-refractory acute lymphoblastic leukemia (ALL) experienced poor outcomes with intensive chemotherapy. This mature analysis explores the benefit of the addition of sequential blinatumomab to low-intensity mini-Hyper-CVD chemotherapy with inotuzumab ozogam...

Descripción completa

Detalles Bibliográficos
Autores principales: Kantarjian, Hagop, Haddad, Fadi G., Jain, Nitin, Sasaki, Koji, Short, Nicholas J., Loghavi, Sanam, Kanagal-Shamanna, Rashmi, Jorgensen, Jeffrey, Khouri, Issa, Kebriaei, Partow, Alvarado, Yesid, Kadia, Tapan, Paul, Shilpa, Garcia-Manero, Guillermo, Dabaja, Bouthaina, Yilmaz, Musa, Jacob, Jovitta, Garris, Rebecca, O’Brien, Susan, Ravandi, Farhad, Jabbour, Elias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155451/
https://www.ncbi.nlm.nih.gov/pubmed/37131217
http://dx.doi.org/10.1186/s13045-023-01444-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155451/
https://www.ncbi.nlm.nih.gov/pubmed/37131217
http://dx.doi.org/10.1186/s13045-023-01444-2

Ejemplares similares